Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
Airbus CEO Warns Staff to Prepare for Rising Geopolitical Risks Amid Trade Tensions 
LVMH Succession Uncertainty Raises Governance Concerns Among Shareholders 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Ryanair Profit Slumps in Q3 After Italy Antitrust Fine Despite Revenue Growth 
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation 
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House 
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
BURLINGTON, Mass., May 11, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Investor Conference in Boston on Wednesday, May 17, 2017 at the Boston Park Plaza. The Company’s presentation is scheduled to begin at 10:00 AM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, June 1, 2017 at the Palmer House Hilton in Chicago, IL.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6, 2017 at the Grand Hyatt in New York, NY. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]
